Raphael Augusto Correa Bastianon Santiago

Dr. Raphael Augusto Correa Bastianon Santiago

Department of Neurosurgery and Neurology, Cleveland Clinic Florida, Weston, Connecticut, USA
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2023 in Heliyon
Verified
Journal Article
Open access
AAAssad Ali
Assad Ali
Raphael Augusto Correa Bastianon SantiagoRaphael Augusto Correa Bastianon Santiago
Raphael Augusto Correa Bastianon Santiago
JIJulio Isidor
Julio Isidor
MMMauricio Mandel
Mauricio Mandel
MAMohamad Adada
Mohamad Adada
HBHamid Borghei-Razavi
Hamid Borghei-Razavi
Idiopathic intracranial hypertension (IIH) is characterized by raised intracranial pressure with unknown etiology. The most common neurological manifestations are headache and visual loss. Often, other cranial nerve impairments are also found, most commonly in the VI nerve. Trigeminal neuralgia (TN) is a debilitating condition that is most frequently caused by neurovascular pathology, but TN secondary to IIH is a rare and poorly described topic. Possible explanations of TN in these patients include the distortion of the local anatomy at CN entry zones and fluid displacement causing distortion of the Meckel's cave. In the case below we describe the clinical course of an obese female patient with TN-like pain who underwent a ventriculoperitoneal shunt to treat IIH and experienced complete resolution of both conditions.

16 November 2022 in World Neurosurgery
Verified
Journal Article
Closed access
JCJuan P. Cabrera
Juan P. Cabrera
CCCharles A. Carazzo
Charles A. Carazzo
AGAlfredo Guiroy
Alfredo Guiroy
KWKevin P. White
Kevin P. White
JGJoana Guasque
Joana Guasque
AGAlvaro Silva Gonzalez
Alvaro Silva Gonzalez

2 March 2024 in World Neurosurgery: X
Verified
Journal Article
Open access
Raphael Augusto Correa Bastianon SantiagoRaphael Augusto Correa Bastianon Santiago
Raphael Augusto Correa Bastianon Santiago
CJCamille Jastrzebski
Camille Jastrzebski
EDElias Dakwar
Elias Dakwar
BABadih Adada
Badih Adada
HBHamid Borghei-Razavi
Hamid Borghei-Razavi
MOMichal Obrzut
Michal Obrzut

30 April 2023 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
RSRomel Corecha Santos
Romel Corecha Santos
BGBhavika Gupta
Bhavika Gupta
Raphael Augusto Correa Bastianon SantiagoRaphael Augusto Correa Bastianon Santiago
Raphael Augusto Correa Bastianon Santiago
MSMohammadmahdi Sabahi
Mohammadmahdi Sabahi
BKBrandon Young Kaye
Brandon Young Kaye
HBHamid Borghei-Razavi
Hamid Borghei-Razavi

12 May 2023 in Current Oncology
Verified
Journal Article
Open access
PDF file
BKBrandon Young Kaye
Brandon Young Kaye
AAAssad Ali
Assad Ali
Raphael Augusto Correa Bastianon SantiagoRaphael Augusto Correa Bastianon Santiago
Raphael Augusto Correa Bastianon Santiago
HBHamid Borghei-Razavi
Hamid Borghei-Razavi
JIJulio Isidor
Julio Isidor
HBHamid Borghei-Razavi
Hamid Borghei-Razavi
Introduction: Glioblastoma (GBM) patients have a 20–30 incidence of venous thromboembolic events. EGFR is a widely used prognostic marker for many cancers. Recent lung cancer studies have described relationships between EGFR amplification and an increased incidence of thromboembolic complications. We aim to explore this relationship in glioblastoma patients. Methods: Two hundred ninety-three consecutive patients with IDH wild-type GBM were included in the analysis. The amplification status of EGFR was measured using fluorescence in situ hybridization (FISH). Centromere 7 (CEP7) expression was recorded to calculate the EGFR-to-CEP7 ratio. All data were collected retrospectively through chart review. Molecular data were obtained through the surgical pathology report at the time of biopsy. Results: There were 112 subjects who were EGFR-amplified (38.2%) and 181 who were non-amplified (61.8%). EGFR amplification status was not significantly correlated with VTE risk overall (p = 0.2001). There was no statistically significant association between VTE and EGFR status after controlling for Bevacizumab therapy (p = 0.1626). EGFR non-amplified status was associated with an increased VTE risk in subjects greater than 60 years of age (p = 0.048). Conclusions: There was no significant difference in occurrence of VTE in patients with glioblastoma, regardless of EGFR amplification status. Patients older than 60 years of age with EGFR amplification experienced a lower rate of VTE, contrary to some reports on non-small-cell lung cancer linking EGFR amplification to VTE risk.

4 October 2022 in Current Oncology
Verified
Journal Article
Open access
PDF file
BKBrandon Young Kaye
Brandon Young Kaye
Raphael Augusto Correa Bastianon SantiagoRaphael Augusto Correa Bastianon Santiago
Raphael Augusto Correa Bastianon Santiago
GMGerard MacKinnon
Gerard MacKinnon
RDRocco Dabecco
Rocco Dabecco
BIBilal Ibrahim
Bilal Ibrahim
BABadih Adada
Badih Adada
Introduction: Resection of intra-axial tumors (IaT) in eloquent brain regions risks major postoperative neurological deficits. Awake craniotomy is often used to navigate these areas; however, some patients are ineligible for awake procedures. The trans-sulcal approach (TScal) was introduced to reduce parenchymal trauma during tumor resection. We report our experiences utilizing TScal for resection of deep IaT located in eloquent areas. Materials and Methods: This is a single-center retrospective analysis of patients who underwent IaT resection in eloquent areas via TScal from January 2013 to April 2021. Seventeen cases were reviewed, and relevant data was collected. Fluorescence-guided surgery with 5-aminolevulinic acid (ALA) and intraoperative ultrasound was performed in some cases. Results: Seventeen patients (10 males, 7 females) averaging 61.2 years-old (range, 21–76) were included in this study. Average length of stay was 4.8 days, and only 2 patients (11.8%) required hospital readmission within 30 days. Gross total resection (GTR) was achieved in 15 patients (88.2%), while subtotal resection occurred in 2 patients (11.8%). Eleven patients (64.7%) reported full resolution of symptoms, 4 patients (23.5%) reported deficit improvement, and 2 patients (11.8%) experienced no change from their preoperative deficits. No patient developed new permanent deficits postoperatively. Discussion: GTR, preoperative deficit reduction, and complications were comparable to awake craniotomy and other TScal studies. Ancillary intraoperative techniques, such as brain mapping, 5-ALA and intraoperative ultrasound, are afforded by TScal to improve resection rates and overall outcomes. Conclusions: TScal can be an option for patients with deep lesions in eloquent areas who are not candidates for awake surgeries.